Wolverine World Wide

▲ Bull Case

• ◆Saucony replicating Hoka-like trajectory with 20%+ growth and 22%+ durable margins to $1B+ revenue. Q1 FY26 accelerated to +20.1% on $129.8M base. Brand's 127-year heritage + PWRRUN PB foam process innovation + elite-athlete co-design (Kipchoge) + distribution breadth create defensible moat. If Saucony reaches $1B by FY28 at 22%+ op margin, segment value alone ($1.2-1.5B) justifies portfolio re-rating. Incremental Saucony revenue at 25-30% margin provides 200+ bps consolidated operating leverage; path to $250M+ annual op income and EPS $2.00+ by FY27-FY28 is credible.
• ◆Balance sheet no longer binary risk; capital return optionality unlocks Stage 3 inflection. Debt reduced $1.1B over 3 years; 3.3x net leverage at FY25-end with $600M undrawn revolver. At $150M annual FCF run-rate, leverage drops below 2.5x by late FY26/early FY27. Buyback resumption ($100-200M annually) adds 3-5% EPS accretion on top of organic growth. CEO Hufnagel's open-market buy at $14.77 (Feb 2025) signals conviction at trough; insider alignment (60% PSU tied to relative TSR, cumulative EPS, FCF) ensures Stage-2 delivery probable.
• ◆Active Group at $1.4B revenue now in SG&A leverage zone; margin expansion to 10%+ consolidated not yet priced. FY25 gross margin jumped 300 bps to 47.3%; operating margin doubled to 8.0%. As Saucony grows incremental 18-20% on fixed SG&A base, consolidated op margin expands 100-150 bps annually through FY27-FY28. Terminal op margin of 11-12% on $2.0B+ revenue is achievable; at 13x EV/EBITDA on $240M EBITDA, equity value reaches $30-35 per share by FY28-FY29.

▼ Bear Case

• ◆Saucony growth deceleration to mid-single digits breaks entire Stage-2 narrative. Q1 FY26 +20% lapped weak Q1 FY25. If deceleration to +8-10% in Q2-Q3 FY26 as comparisons toughen, 'Hoka-like scale story' loses credibility. Consensus re-rates to 10x P/E on FY27 EPS $1.20-1.30, implying stock price of $12-13. Competitive response from Hoka, Brooks, On, ASICS in performance-running is real and not yet fully priced in margin expectations.
• ◆Tariff escalation erodes gross margin faster than price increases offset, capping operating margin at 8%. US footwear tariffs at 25-30%; even marginal increments (5-10 pp) absorb 150-300 bps margin if sourcing not diversified (WWW ~60% Asia). If company cannot raise prices fully due to wholesale channel margin needs or consumer trade-down risk, FY26 gross margin stays 45% vs current 47%, operating margin falls to 7.5% vs guidance-implied 8.5%, and EPS misses to $1.25 vs Co. $1.50 midpoint. At 10.5x P/E, stock trades $13.
• ◆PFAS landfill suit settlement could be $50-100M+ incremental vs reserved $26.5M, forcing debt raise or equity dilution. December 2025 suit is open; company has not given numerical tail-risk guidance. Historical PFAS litigation (Plainfield/Algoma consent $69.5M cap) suggests tail is real. If settlement lands $75-100M, forces either revolver draw to $600M+ (leverage 3.6x+) or equity raise at inopportune moment, diluting shareholders and delaying Stage 3 inflection. Market pricing $26.5M reserve as sufficient; larger settlement re-rates stock -$1 to -$2/sh.

“Core Disagreement: Is Saucony's 22%+ operating margin durable as brand scales to $1B+ revenue, or will it decelerate to 15-18% as competitors respond? Bulls argue Saucony has differentiated process IP (PWRRUN PB foam, elite athlete co-design, product-cycle velocity) creating defensible moat comparable to Hoka's counter-positioning. At $1B revenue on 22% op margin, segment worth $1.2-1.5B (1.8-2.0x EV/Rev consistent with Hoka valuations). Implies $240-260M consolidated operating income by FY28, EPS $2.00+, re-rating from 10.6x to 14-15x justified. Bears argue Saucony is well-executed but not structurally differentiated vs Hoka, Brooks, ASICS, Salomon. As brand scales, competitive response (foam innovation, marketing erosion, margin compression) pushes op margin to 15-18%. A 17% margin on $1B implies $170M segment income vs $220M bulls assume, caps consolidated op income at $210-220M and EPS at $1.70-1.80, re-rating at 12x ($20-22) vs bull 14-15x. Secondary Debate: Tariff Pass-Through Sustainability—bulls assume price increases stick and tariffs half-absorbed by margins; bears assume consumer pushback in competitive running limits pass-through and incremental margin erosion is faster.”

• ◆Q2 FY26 Earnings (Aug 2026): Saucony YoY growth (target +16%+), Active Group total growth, gross margin hold (47%+), EPS vs guidance. Bull: Saucony +17%, GM 47.5%, EPS $0.38 → guide raise to $1.55-$1.65, stock re-rates to $19-20. Bear: Saucony +10%, GM 46%, EPS $0.33 → stock stalls at $15-16. Impact: ±$2-3/share.
• ◆Q3 FY26 Earnings (Nov 2026): Saucony YoY sustainability (must ≥14%), inventory levels (target normalized $250-270M), EPS trend. Bull: FY26 visibility $1.55+, FY27 guide ≥$1.75 → stock consolidates $19-21. Bear: Saucony +8%, guide cut → stock sells to $15. Impact: ±$1-2/share.
• ◆PFAS Landfill Suit Settlement (Late 2026–Early 2027): December 2025 litigation reaches settlement/verdict. Bull: settlement <$35M incremental → stock re-rates +$0.50-$1.00 as overhang lifts. Bear: settlement $50-100M+ → forced debt increase or equity raise, stock cuts -$0.75-$1.50. Impact: ±$1.00/share binary.
• ◆FY27 Buyback Announcement (Q4 FY26 or Q1 FY27): Management announces share buybacks as leverage approaches <2.5x target. Bull: ≥$100-150M annual program announced → 3-4% EPS accretion, stock re-rates to 14x FY27 EPS $1.70-1.75 = $23-25. Bear: buyback delayed → stock caps at $19-21. Impact: +$2-3/share if announced.
• ◆Sr. Notes Refinance Messaging (FY27-FY28): Management provides guidance on refinancing $550M 4.0% Sr. Notes due Aug 2029. Bull: early refinance at 5-5.5% or payoff below $500M debt → Stage 3 completion signal, +$1-2/share. Bear: market forces 6%+ refi → uncertainty persists. Impact: +$1-2/share if de-risked.

• ◆Saucony Growth Deceleration <10% YoY (P1—THESIS KILL, -25% downside): If growth drops below 10% for 2+ consecutive quarters starting Q2 FY26, Stage-2 transformation narrative breaks. Bull-case FY28 EPS ($2.00+) fades to $1.30-1.40; stock re-rates from 13-14x to 10x = $13-14. Probability 15-20%. Mitigation: monitor Q2 FY26 guide, running specialty retailer commentary, brand health.
• ◆Tariff Pass-Through Limitation & Gross Margin Compression (P1—HIGH, -$0.25-$0.30 EPS, -15% stock): Tariff escalation (5-10 pp increments) compresses margin faster than price increases offset. Each 100 bps GM loss = ~$20M operating income. If pass-through limited, FY26 margin stays 45% vs 47%, op margin falls to 7.5%, EPS misses to $1.25, stock trades 10.5x = $13. Probability 25-30%. Mitigation: track Q2 GM vs baseline, tariff-mitigation commentary, wholesale feedback.
• ◆PFAS Landfill Suit Settlement >$100M Incremental (P2—MEDIUM, -$0.75–$1.00 EPS one-time, +$1-2 stock downside): December 2025 suit open with no disclosed tail-risk numerics. Historical litigation (Plainfield $69.5M, Algoma) suggests large settlements possible. If $75-100M+, forces revolver draw (3.6x+ leverage) or equity raise, delaying Stage 3. One-time charge $0.75-$1.00/share; 2-3% dilution; PFAS overhang prevents multiple expansion. Probability 10-15%. Mitigation: demand clarity on settlement range in Q2 call.
• ◆Work Group Accelerates Decline >-15% YoY (P2—MEDIUM, -$0.30 EPS, -10% stock): Work Group ($422M, 23% revenue) declining -7.3% FY25. If housing/construction softens or heritage brands lose to Red Wing/Caterpillar/Timberland, segment decelerates to -10% to -15%, margin compresses 17% to 14-15%, becomes consolidated drag. Revenue growth slows to 3-4%, op margin stalls at 8.5%, EPS capped at $1.60 vs $1.75 bull. Probability 20-25%. Mitigation: monitor Q2 Work Group growth, housing starts, construction PMI.
• ◆Macro Recession & Consumer Discretionary Pullback (P2—MEDIUM, -10-15% stock downside, 12-month Stage 3 delay): Consumer credit stress or retail destocking in late 2026/early 2027 pressures wholesale orders. Saucony decelerates from 20% to 5-8% as retailers cut inventory. FY27 EPS drops to $1.50-1.60 vs $1.75+ bull; Stage 3 pushed to FY28-FY29. Stock re-rates from 13.5x to 12x on lower FY27 EPS = $18-19 vs base $20. Probability 15-20%. Mitigation: monitor yield curve, unemployment, credit data, wholesale order book.